• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉生长抑制素抑制可预防脂肪营养不良小鼠模型的糖尿病和多食症。

Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy.

机构信息

Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Diabetes. 2012 Oct;61(10):2414-23. doi: 10.2337/db11-0915. Epub 2012 May 17.

DOI:10.2337/db11-0915
PMID:22596054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3447905/
Abstract

Lipodystrophies are characterized by a loss of white adipose tissue, which causes ectopic lipid deposition, peripheral insulin resistance, reduced adipokine levels, and increased food intake (hyperphagia). The growth factor myostatin (MSTN) negatively regulates skeletal muscle growth, and mice with MSTN inhibition have reduced adiposity and improved insulin sensitivity. MSTN inhibition may therefore be efficacious in ameliorating diabetes. To test this hypothesis, we inhibited MSTN signaling in a diabetic model of generalized lipodystrophy to analyze its effects on glucose metabolism separate from effects on adipose mass. A-ZIP/F1 lipodystrophic mice were crossed to mice expressing a dominant-negative MSTN receptor (activin receptor type IIB) in muscle. MSTN inhibition in A-ZIP/F1 mice reduced blood glucose, serum insulin, triglyceride levels, and the rate of triglyceride synthesis, and improved insulin sensitivity. Unexpectedly, hyperphagia was normalized by MSTN inhibition in muscle. Blood glucose and hyperphagia were reduced in double mutants independent of the adipokine leptin. These results show that the effect of MSTN inhibition on insulin sensitivity is not secondary to an effect on adipose mass and that MSTN inhibition may be an effective treatment for diabetes. These results further suggest that muscle may play a heretofore unappreciated role in regulating food intake.

摘要

脂肪营养不良的特征是白色脂肪组织的丧失,这会导致异位脂质沉积、外周胰岛素抵抗、降低脂肪因子水平和增加食物摄入(贪食症)。生长因子肌肉生长抑制素 (MSTN) 负调节骨骼肌生长,而 MSTN 抑制的小鼠脂肪减少,胰岛素敏感性提高。因此,MSTN 抑制可能在改善糖尿病方面有效。为了验证这一假设,我们在全身性脂肪营养不良的糖尿病模型中抑制 MSTN 信号转导,以分析其对葡萄糖代谢的影响,而不考虑对脂肪质量的影响。A-ZIP/F1 脂肪营养不良小鼠与肌肉中表达显性负性 MSTN 受体(激活素受体 IIB)的小鼠杂交。A-ZIP/F1 小鼠中 MSTN 的抑制降低了血糖、血清胰岛素、甘油三酯水平和甘油三酯合成率,并改善了胰岛素敏感性。出乎意料的是,肌肉中 MSTN 的抑制使贪食症正常化。双突变体中的血糖和贪食症降低与脂肪因子瘦素无关。这些结果表明,MSTN 抑制对胰岛素敏感性的影响不是继发于对脂肪质量的影响,并且 MSTN 抑制可能是治疗糖尿病的有效方法。这些结果进一步表明,肌肉可能在调节食物摄入方面发挥了迄今为止尚未被认识到的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/22ee691e56a6/2414fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/12a9c1192b93/2414fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/55ebd1a2a1a2/2414fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/9197642dde76/2414fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/99708896873b/2414fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/e05443d91b1b/2414fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/22ee691e56a6/2414fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/12a9c1192b93/2414fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/55ebd1a2a1a2/2414fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/9197642dde76/2414fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/99708896873b/2414fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/e05443d91b1b/2414fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bd5/3447905/22ee691e56a6/2414fig6.jpg

相似文献

1
Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy.肌肉生长抑制素抑制可预防脂肪营养不良小鼠模型的糖尿病和多食症。
Diabetes. 2012 Oct;61(10):2414-23. doi: 10.2337/db11-0915. Epub 2012 May 17.
2
Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.肌肉而非脂肪组织中的肌生成抑制素抑制作用可减少脂肪量并改善胰岛素敏感性。
PLoS One. 2009;4(3):e4937. doi: 10.1371/journal.pone.0004937. Epub 2009 Mar 19.
3
Soluble activin receptor type IIB treatment does not cause fat loss in mice with diet-induced obesity.可溶性激活素受体 IIB 治疗不会导致饮食诱导肥胖的小鼠体重减轻。
Diabetes Obes Metab. 2012 Mar;14(3):279-82. doi: 10.1111/j.1463-1326.2011.01520.x. Epub 2011 Nov 21.
4
Loss-of-function myostatin mutation increases insulin sensitivity and browning of white fat in Meishan pigs.功能丧失型肌生成抑制素突变增加了梅山猪的胰岛素敏感性和白色脂肪的褐色化。
Oncotarget. 2017 May 23;8(21):34911-34922. doi: 10.18632/oncotarget.16822.
5
Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance.肌肉生长抑制素功能丧失突变可降低肿瘤坏死因子α的产生,并保护肝脏免受肥胖诱导的胰岛素抵抗。
Diabetes. 2009 May;58(5):1133-43. doi: 10.2337/db08-0245. Epub 2009 Feb 10.
6
A soluble activin receptor type IIB does not improve blood glucose in streptozotocin-treated mice.可溶性IIB型激活素受体不能改善链脲佐菌素处理小鼠的血糖水平。
Int J Biol Sci. 2015 Jan 5;11(2):199-208. doi: 10.7150/ijbs.10430. eCollection 2015.
7
Increasing muscle mass to improve metabolism.增加肌肉量以改善新陈代谢。
Adipocyte. 2013 Apr 1;2(2):92-8. doi: 10.4161/adip.22500.
8
Myostatin propeptide mutation of the hypermuscular mice decreases the formation of myostatin and improves insulin sensitivity.超级肌肉小鼠的肌生成抑制素前肽突变减少了肌生成抑制素的形成并改善了胰岛素敏感性。
Am J Physiol Endocrinol Metab. 2017 Mar 1;312(3):E150-E160. doi: 10.1152/ajpendo.00216.2016. Epub 2016 Dec 13.
9
Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake.肌肉生长抑制素通过 Casitas B 细胞淋巴瘤 b(Cblb)介导的胰岛素受体底物 1(IRS1)蛋白降解,诱导胰岛素抵抗,以响应高卡路里饮食摄入。
J Biol Chem. 2014 Mar 14;289(11):7654-70. doi: 10.1074/jbc.M113.529925. Epub 2014 Jan 22.
10
Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway.肌抑素缺失小鼠通过激活 AMP 激活的蛋白激酶信号通路来减少胰岛素抵抗。
Diabetologia. 2011 Jun;54(6):1491-501. doi: 10.1007/s00125-011-2079-7. Epub 2011 Feb 24.

引用本文的文献

1
Diabetes Mellitus Should Be Considered While Analysing Sarcopenia-Related Biomarkers.在分析与肌肉减少症相关的生物标志物时应考虑糖尿病。
J Clin Med. 2024 Feb 15;13(4):1107. doi: 10.3390/jcm13041107.
2
Myostatin: a potential therapeutic target for metabolic syndrome.肌肉生长抑制素:代谢综合征的潜在治疗靶点。
Front Endocrinol (Lausanne). 2023 May 23;14:1181913. doi: 10.3389/fendo.2023.1181913. eCollection 2023.
3
Leptin mediates the regulation of muscle mass and strength by adipose tissue.瘦素通过脂肪组织调节肌肉质量和力量。

本文引用的文献

1
Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass.肌生成抑制蛋白的细胞外调节:肌肉量的分子变阻器
Immunol Endocr Metab Agents Med Chem. 2010;10:183-194. doi: 10.2174/187152210793663748.
2
METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.肌肉生长抑制素和生长分化因子11的代谢功能
Immunol Endocr Metab Agents Med Chem. 2010 Dec;10(4):217-231. doi: 10.2174/187152210793663810.
3
Lipodystrophy: pathophysiology and advances in treatment.脂肪营养不良:病理生理学和治疗进展。
J Physiol. 2022 Aug;600(16):3795-3817. doi: 10.1113/JP283034. Epub 2022 Aug 2.
4
Does a Hypertrophying Muscle Fibre Reprogramme its Metabolism Similar to a Cancer Cell?肥大的肌纤维是否会像癌细胞一样重新编程其代谢?
Sports Med. 2022 Nov;52(11):2569-2578. doi: 10.1007/s40279-022-01676-1. Epub 2022 Apr 23.
5
The Proteomic Signature of Recombinant Growth Hormone in Recreational Athletes.职业运动员中重组生长激素的蛋白质组学特征
J Endocr Soc. 2021 Nov 2;5(12):bvab156. doi: 10.1210/jendso/bvab156. eCollection 2021 Dec 1.
6
Impaired Muscle Mitochondrial Function in Familial Partial Lipodystrophy.家族性部分脂肪营养不良患者的肌肉线粒体功能受损。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):346-362. doi: 10.1210/clinem/dgab725.
7
Myostatin serum levels in children with type 1 diabetes mellitus.1 型糖尿病患儿血清肌肉抑制素水平。
Hormones (Athens). 2021 Dec;20(4):777-782. doi: 10.1007/s42000-021-00317-y. Epub 2021 Sep 6.
8
Identification of Molecules from Coffee Silverskin That Suppresses Myostatin Activity and Improves Muscle Mass and Strength in Mice.鉴定咖啡银皮中抑制肌肉生长抑制素活性并提高小鼠肌肉质量和力量的分子。
Molecules. 2021 May 3;26(9):2676. doi: 10.3390/molecules26092676.
9
Regulation of circulating CTRP-2/CTRP-9 and GDF-8/GDF-15 by intralipids and insulin in healthy control and polycystic ovary syndrome women following chronic exercise training.脂联素和胰岛素对健康对照组和多囊卵巢综合征患者循环 CTRP-2/CTRP-9 和 GDF-8/GDF-15 的调节作用:慢性运动训练后的变化。
Lipids Health Dis. 2021 Apr 19;20(1):34. doi: 10.1186/s12944-021-01463-3.
10
Metabolic effects of air pollution exposure and reversibility.空气污染暴露与可逆转性的代谢影响。
J Clin Invest. 2020 Nov 2;130(11):6034-6040. doi: 10.1172/JCI137315.
Nat Rev Endocrinol. 2011 Mar;7(3):137-50. doi: 10.1038/nrendo.2010.199. Epub 2010 Nov 16.
4
Lipid-induced insulin resistance: unravelling the mechanism.脂毒性诱导的胰岛素抵抗:机制解析。
Lancet. 2010 Jun 26;375(9733):2267-77. doi: 10.1016/S0140-6736(10)60408-4.
5
Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice.产后过氧化物酶体增殖物激活受体 δ 的激活和肌肉生长抑制素的抑制对肥胖胰岛素抵抗小鼠的代谢特征具有显著且互补的作用。
PLoS One. 2010 Jun 25;5(6):e11307. doi: 10.1371/journal.pone.0011307.
6
The role of gut hormones and the hypothalamus in appetite regulation.肠道激素和下丘脑在食欲调节中的作用。
Endocr J. 2010;57(5):359-72. doi: 10.1507/endocrj.k10e-077. Epub 2010 Apr 14.
7
Myostatin decreases with aerobic exercise and associates with insulin resistance.肌肉生长抑制素会随着有氧运动而减少,并与胰岛素抵抗有关。
Med Sci Sports Exerc. 2010 Nov;42(11):2023-9. doi: 10.1249/MSS.0b013e3181e0b9a8.
8
Glucagon regulation of energy metabolism.胰高血糖素对能量代谢的调节。
Physiol Behav. 2010 Jul 14;100(5):545-8. doi: 10.1016/j.physbeh.2010.03.019. Epub 2010 Apr 8.
9
Neuronal regulation of homeostasis by nutrient sensing.营养感应的神经元对动态平衡的调节。
Nat Med. 2010 Apr;16(4):392-5. doi: 10.1038/nm0410-392.
10
Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin.Berardinelli-Seip 先天性脂肪营养不良症对瘦素替代治疗的抵抗:免疫学起源。
Eur J Endocrinol. 2010 Jun;162(6):1083-91. doi: 10.1530/EJE-09-1027. Epub 2010 Mar 17.